0001209191-17-056202.txt : 20171005 0001209191-17-056202.hdr.sgml : 20171005 20171005192405 ACCESSION NUMBER: 0001209191-17-056202 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171003 FILED AS OF DATE: 20171005 DATE AS OF CHANGE: 20171005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ruff Shamim CENTRAL INDEX KEY: 0001685986 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 171125539 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-10-03 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001685986 Ruff Shamim 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 0 1 0 0 SVP, Regulatory Affairs & Qual Common Stock 2017-10-03 4 M 0 11500 14.76 A 38545 D Common Stock 2017-10-03 4 S 0 11500 50.00 D 27045 D Non-Qualified Stock Options (right to buy) 14.76 2017-10-03 4 M 0 11500 14.76 D 2016-05-06 2025-05-06 Common Stock 11500 41144 D This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on May 12, 2017, accordingly, the reporting person had no discretion with regards to the timing of the transaction. /s/David Tyronne Howton, as Attorney-in-Fact for Shamim Ruff 2017-10-05